Will vcnx surge today

Vaccinex (VCNX) is unlikely to surge today. Here's why:

1. Recent Price Movement: Vaccinex has not seen any significant price increase as of the last quarter growth value, which is reported as 0.

2. Clinical Trial Updates: While the company has reported the completion of the last patient visit in the SIGNAL-AD Phase 1b/2 study of Pepinemab treatment for Alzheimer's Disease, this event alone may not be sufficient to drive a substantial surge in the stock price.
3. Financial Performance: The company's financial results for the first quarter of 2024 and the previous year do not provide a clear indication of an imminent surge in the stock price.
4. Corporate Activity: Recent corporate updates, including the signing of multi-project deals and a reverse stock split, do not appear to be directly related to a surge in the stock price.
5. Industry Events: The company's participation in industry events, such as the Immuno-Oncology Summit 2024, may not have an immediate impact on the stock price.

In conclusion, while Vaccinex has been actively engaged in research and development, the absence of specific catalysts or positive financial indicators suggests that the stock is not poised for a surge today.